652 related articles for article (PubMed ID: 31443646)
1. Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa?
Foguim Tsombeng F; Gendrot M; Robert MG; Madamet M; Pradines B
Malar J; 2019 Aug; 18(1):285. PubMed ID: 31443646
[TBL] [Abstract][Full Text] [Related]
2. No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China-Myanmar border.
Huang F; Shrestha B; Liu H; Tang LH; Zhou SS; Zhou XN; Takala-Harrison S; Ringwald P; Nyunt MM; Plowe CV
Malar J; 2020 Sep; 19(1):334. PubMed ID: 32928233
[TBL] [Abstract][Full Text] [Related]
3. Absence of a High Level of Duplication of the Plasmepsin II Gene in Africa.
Robert MG; Foguim Tsombeng F; Gendrot M; Mosnier J; Amalvict R; Benoit N; Torrentino-Madamet M; Pradines B;
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181370
[TBL] [Abstract][Full Text] [Related]
4. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study.
Witkowski B; Duru V; Khim N; Ross LS; Saintpierre B; Beghain J; Chy S; Kim S; Ke S; Kloeung N; Eam R; Khean C; Ken M; Loch K; Bouillon A; Domergue A; Ma L; Bouchier C; Leang R; Huy R; Nuel G; Barale JC; Legrand E; Ringwald P; Fidock DA; Mercereau-Puijalon O; Ariey F; Ménard D
Lancet Infect Dis; 2017 Feb; 17(2):174-183. PubMed ID: 27818097
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine.
Loesbanluechai D; Kotanan N; de Cozar C; Kochakarn T; Ansbro MR; Chotivanich K; White NJ; Wilairat P; Lee MCS; Gamo FJ; Sanz LM; Chookajorn T; Kümpornsin K
Int J Parasitol Drugs Drug Resist; 2019 Apr; 9():16-22. PubMed ID: 30580023
[TBL] [Abstract][Full Text] [Related]
6. Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study.
Amato R; Lim P; Miotto O; Amaratunga C; Dek D; Pearson RD; Almagro-Garcia J; Neal AT; Sreng S; Suon S; Drury E; Jyothi D; Stalker J; Kwiatkowski DP; Fairhurst RM
Lancet Infect Dis; 2017 Feb; 17(2):164-173. PubMed ID: 27818095
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of Plasmepsins 2 and 3 Sensitizes Plasmodium falciparum to the Antimalarial Drug Piperaquine.
Mukherjee A; Gagnon D; Wirth DF; Richard D
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439977
[TBL] [Abstract][Full Text] [Related]
8. Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia.
Mukherjee A; Bopp S; Magistrado P; Wong W; Daniels R; Demas A; Schaffner S; Amaratunga C; Lim P; Dhorda M; Miotto O; Woodrow C; Ashley EA; Dondorp AM; White NJ; Wirth D; Fairhurst R; Volkman SK
Malar J; 2017 May; 16(1):195. PubMed ID: 28494763
[TBL] [Abstract][Full Text] [Related]
9. Insight into k13-propeller gene polymorphism and ex vivo DHA-response profiles from Cameroonian isolates.
Menard S; Tchoufack JN; Maffo CN; Nsango SE; Iriart X; Abate L; Tsapi MT; Awono-Ambéné PH; Abega Mekongo FA; Morlais I; Berry A
Malar J; 2016 Nov; 15(1):572. PubMed ID: 27887614
[TBL] [Abstract][Full Text] [Related]
10. Local emergence in Amazonia of
Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L
Elife; 2020 May; 9():. PubMed ID: 32394893
[TBL] [Abstract][Full Text] [Related]
11. Evaluations of candidate markers of dihydroartemisinin-piperaquine resistance in Plasmodium falciparum isolates from the China-Myanmar, Thailand-Myanmar, and Thailand-Cambodia borders.
Ye R; Zhang Y; Zhang D
Parasit Vectors; 2022 Apr; 15(1):130. PubMed ID: 35413937
[TBL] [Abstract][Full Text] [Related]
12. African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker.
Leroy D; Macintyre F; Adoke Y; Ouoba S; Barry A; Mombo-Ngoma G; Ndong Ngomo JM; Varo R; Dossou Y; Tshefu AK; Duong TT; Phuc BQ; Laurijssens B; Klopper R; Khim N; Legrand E; Ménard D
Malar J; 2019 Apr; 18(1):126. PubMed ID: 30967148
[TBL] [Abstract][Full Text] [Related]
13. Plasmodium berghei K13 Mutations Mediate
Simwela NV; Stokes BH; Aghabi D; Bogyo M; Fidock DA; Waters AP
mBio; 2020 Nov; 11(6):. PubMed ID: 33173001
[TBL] [Abstract][Full Text] [Related]
14. Plasmodium falciparum Plasmepsin 2 Duplications, West Africa.
Inoue J; Silva M; Fofana B; Sanogo K; Mårtensson A; Sagara I; Björkman A; Veiga MI; Ferreira PE; Djimde A; Gil JP
Emerg Infect Dis; 2018 Aug; 24(8):1591-3. PubMed ID: 29798744
[TBL] [Abstract][Full Text] [Related]
15. Association of a Novel Mutation in the Plasmodium falciparum Chloroquine Resistance Transporter With Decreased Piperaquine Sensitivity.
Agrawal S; Moser KA; Morton L; Cummings MP; Parihar A; Dwivedi A; Shetty AC; Drabek EF; Jacob CG; Henrich PP; Parobek CM; Jongsakul K; Huy R; Spring MD; Lanteri CA; Chaorattanakawee S; Lon C; Fukuda MM; Saunders DL; Fidock DA; Lin JT; Juliano JJ; Plowe CV; Silva JC; Takala-Harrison S
J Infect Dis; 2017 Aug; 216(4):468-476. PubMed ID: 28931241
[TBL] [Abstract][Full Text] [Related]
16. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.
Amaratunga C; Lim P; Suon S; Sreng S; Mao S; Sopha C; Sam B; Dek D; Try V; Amato R; Blessborn D; Song L; Tullo GS; Fay MP; Anderson JM; Tarning J; Fairhurst RM
Lancet Infect Dis; 2016 Mar; 16(3):357-65. PubMed ID: 26774243
[TBL] [Abstract][Full Text] [Related]
17. Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in The Guianas: a descriptive epidemiological study.
Florimond C; de Laval F; Early AM; Sauthier S; Lazrek Y; Pelleau S; Monteiro WM; Agranier M; Taudon N; Morin F; Magris M; Lacerda MVG; Viana GMR; Herrera S; Adhin MR; Ferreira MU; Woodrow CJ; Awab GR; Cox H; Ade MP; Mosnier E; Djossou F; Neafsey DE; Ringwald P; Musset L
Lancet Infect Dis; 2024 Feb; 24(2):161-171. PubMed ID: 37858325
[TBL] [Abstract][Full Text] [Related]
18. Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013.
Torrentino-Madamet M; Fall B; Benoit N; Camara C; Amalvict R; Fall M; Dionne P; Ba Fall K; Nakoulima A; Diatta B; Diemé Y; Ménard D; Wade B; Pradines B
Malar J; 2014 Dec; 13():472. PubMed ID: 25471113
[TBL] [Abstract][Full Text] [Related]
19. A Variant PfCRT Isoform Can Contribute to
Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
mBio; 2017 May; 8(3):. PubMed ID: 28487425
[TBL] [Abstract][Full Text] [Related]
20. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
